ChinaDaily Briefs

Daily Brief China: Trio Industrial Electronics Group, Moore Threads Technology, JD Logistics, NAURA Technology Group, Suzhou Dongshan Precision A, Shandong Linuo Pharmaceutical Packaging, Beijing QL Biopharmaceutical, EcoCeres, MiniMax, Anhui Sinomags Technology and more

In today’s briefing:

  • More Contractor Craziness. The HKEx Needs To Open An Investigation
  • Aequitas: Moore Threads Technology A/H Listing – Peer Comparison and Thoughts on Valuations
  • JD Logistics H1/Q2 Results | Momentum, Profitability Show Mixed Signals | Shares Drained Of Optimism
  • NAURA Technology: From China Champion to Global Contender
  • Suzhou Dongshan Precision A (002384 CH): Synthetic Expert Call Transcript (30 Sep 2026)
  • IPO Databook: Shandong Linuo Pharmaceutical Packaging (301188 HK) – Sep 2026
  • Pre-IPO Beijing QL Biopharmaceutical – Valuation Premiums Are Highly Likely
  • EcoCeres Pre-IPO Note: The Price of Decarbonising Aviation
  • EQD | Hong Kong October 2026 Monthly Covered Call Report
  • IPO Databook: Anhui Sinomags Technology (HK) – Sep 2026


More Contractor Craziness. The HKEx Needs To Open An Investigation

By David Blennerhassett


Aequitas: Moore Threads Technology A/H Listing – Peer Comparison and Thoughts on Valuations

By Sumeet Singh

  • Moore Threads Technology (688795 CH) (MTT), a domestic GPU producer, aims to raise over >US$1bn in its H-share listing.
  • MTT mainly engages in the research, design, and sales of GPUs and related products. It listed its A-shares just last year.
  • We looked at its past performance in our earlier note. In this note, undertake a peer comparison and talk about valuations.

JD Logistics H1/Q2 Results | Momentum, Profitability Show Mixed Signals | Shares Drained Of Optimism

By Daniel Hellberg

  • In H1 and Q2 this year, JD Logistics’ top-line growth remained strong, growing by 20%+
  • But margins have continued to erode in recent periods, probably due to changes in mix
  • Down close to HK$10 per share, we believe lots of negativity is “baked in” to price

NAURA Technology: From China Champion to Global Contender

By Steven Holden

  • NAURA ownership has surged seven-fold since 2023: 18.3% of active funds now hold it, with $2.4bn invested and holders running a committed 1.86% average position.
  • The register is built on emerging markets: owned by 63% of China A-Share funds and 22% of GEM funds, with GEM investors leading 2026’s buying.
  • Global and ACWI ex-USA funds hold nearly $15bn in NAURA’s listed peers but under $100m in NAURA itself. Breaking into global portfolios is the next leg.

Suzhou Dongshan Precision A (002384 CH): Synthetic Expert Call Transcript (30 Sep 2026)

By αSK SmartScripts

  • Source Photonics Integration as the Core Profit Engine: Following its consolidation in October 2025, Source Photonics has fundamentally reshaped DSBJ’s financial profile, accounting for 52.92% of consolidated net profit in Q1 2026. This vertical integration into high-value Indium Phosphide (InP) EML laser chips offers a structural margin cushion against severe ASP erosion in the pluggable assembly market.
  • The Capital Allocation Paradox of the Hong Kong Listing: The targeted $2 billion to $3 billion Hong Kong IPO—which received CSRC clearance for up to 234.04 million H shares on September 29, 2026—is driven by onshore balance sheet deleveraging and funding the aggressive $1.2 billion domestic capacity expansion for Source Photonics. This heavy domestic spend contrasts with modest capital allocations for Mexico and Southeast Asia, highlighting a strategy that prioritizes technology-heavy domestic capex over rapid geopolitical footprint diversification.
  • Divergent Cyclical Realities (AI vs. Mobile & EV): DSBJ faces a stark divergence between its hyper-growth AI optical and high-layer HDI segments (propelled by North American hyperscaler demand) and its legacy consumer and automotive units. While AI demand is structural and currently constrained only by EML chip and high-frequency copper-clad laminate (CCL) supply, the traditional FPC business (tied to Apple’s smartphone cycle) and the precision automotive metal business (tied to Tesla’s Mexico slowdown) are operating in late-cycle, margin-compressed territory.

Disclaimer: The following transcripts are synthetic, AI-generated on demand, and compiled exclusively from public data sources; no real-word experts were actually interviewed. This content is designed to highlight potential market mispricings, explore compelling lines of inquiry, and suggest strategic questions rather than present verified facts. All specific financial metrics and data points, including market shares, TAM, margins, and growth rates, are AI-estimated approximations. They may be inaccurate and must be independently verified.


IPO Databook: Shandong Linuo Pharmaceutical Packaging (301188 HK) – Sep 2026

By αSK IPO Databooks

  • Shandong Linuo Pharmaceutical Packaging Co.,Ltd. is an established Chinese provider of borosilicate technical glass, specializing in pharmaceutical glass packaging and household heat-resistant glass.
  • The company ranked ninth in China’s pharmaceutical glass packaging market and first in China’s household heat-resistant glass market by sales revenue in 2025.
  • The company reported a decrease in profit for FY2025 and negative net cash from operating activities for FY2025 and H1 2026.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Pre-IPO Beijing QL Biopharmaceutical – Valuation Premiums Are Highly Likely

By Xinyao (Criss) Wang

  • QL adopts a comprehensive business model of “independent R&D + full industrial chain layout + diversified pipeline”.Based on proprietary technology platforms, QL is able to form a structural cost advantage.
  • The competition for GLP-1 is moving from the broad stage to the “efficacy, safety, convenience, and economy” refined competition stage, and QL is facing intense competition in multiple dimensions.
  • With the comprehensive assessment of QL – “no commercialized product + strong pipeline”, and “first mover advantage + product differentiation”, a neutral scenario is HK$15-20 billion market value.

EcoCeres Pre-IPO Note: The Price of Decarbonising Aviation

By Mo Aziz

  • A rare pure-play listing. EcoCeres, a Bain-backed Hong Kong producer of sustainable aviation fuel, targets a ~US$1bn IPO by end-2026, in a market created by law.
  • It lists near a margin peak. The 2026 oil shock inflated SAF profits; in 2024, oversupply more than halved Neste’s margins. Value it on mid-cycle earnings, not the windfall.
  • Price discipline matters. Law-mandated green sectors (solar, wind, renewable fuels) trade at 6–12x EV/EBITDA. The reported US$5bn valuation implies ~14x. Engage below US$3.5bn; pass above US$5bn.

EQD | Hong Kong October 2026 Monthly Covered Call Report

By Nicholas Pezolano

  • Top Hong Kong Stock Exchange listed covered call candidates for the month of October.
  • The top 10 provide an average ~7.42% premium with a potential ~8.82% upside P&L if exercised.
  • Investors with a neutral 1-month view on the underlying can seek to generate income.

IPO Databook: Anhui Sinomags Technology (HK) – Sep 2026

By αSK IPO Databooks

  • Anhui Sinomags Technology is an IDM in the magnetic sensor industry, offering one-stop solutions across diverse industries. The company ranked tenth globally in magnetic sensor revenue in 2025.
  • Anhui Sinomags Technology ranked tenth globally in magnetic sensor revenue in 2025 and fifth in xMR sensor revenue, with revenue increasing 20.2%.
  • The company reported a net profit of RMB52,584 thousand in 2025, following a net loss of RMB66,562 thousand in 2023.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars